These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1409792)

  • 41. Effects of d-amphetamine, morphine, naloxone, and drug combinations on visual discrimination in rats.
    Andrews JS; Holtzman SG
    Psychopharmacology (Berl); 1988; 94(2):172-7. PubMed ID: 3127842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Interactions of dopamine receptor agonists and antagonists with regard to dopamine synthesis and metabolism].
    Kehr W
    Arzneimittelforschung; 1976; 26(6):1086-8. PubMed ID: 9107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. D-amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation.
    Cador M; Bjijou Y; Cailhol S; Stinus L
    Neuroscience; 1999; 94(3):705-21. PubMed ID: 10579562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of self-stimulation behavior in rats and monkeys after chronic neuroleptic treatment: evidence for mesolimbic supersensitivity.
    Seeger TF; Gardner EL
    Brain Res; 1979 Oct; 175(1):49-57. PubMed ID: 114275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amphetamine sensitization in mice is sufficient to produce both manic- and depressive-related behaviors as well as changes in the functional connectivity of corticolimbic structures.
    Pathak G; Ibrahim BA; McCarthy SA; Baker K; Kelly MP
    Neuropharmacology; 2015 Aug; 95():434-47. PubMed ID: 25959066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Response of ventral pallidal neurons to amygdala stimulation and its modulation by dopamine projections to nucleus accumbens.
    Yim CY; Mogenson GJ
    J Neurophysiol; 1983 Jul; 50(1):148-61. PubMed ID: 6875644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.
    Paterson NE; Balfour DJ; Markou A
    Nicotine Tob Res; 2008 Jun; 10(6):995-1008. PubMed ID: 18584463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of fentanyl dose and exposure duration on the affective and somatic signs of fentanyl withdrawal in rats.
    Liu J; Pan H; Gold MS; Derendorf H; Bruijnzeel AW
    Neuropharmacology; 2008 Oct; 55(5):812-8. PubMed ID: 18634811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system.
    Kalivas PW
    J Pharmacol Exp Ther; 1985 Nov; 235(2):544-50. PubMed ID: 4057084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of chronic environmental and social stimuli during adolescence on mesolimbic dopaminergic circuitry markers.
    Kabbaj M; Isgor C
    Neurosci Lett; 2007 Jul; 422(1):7-12. PubMed ID: 17590508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.
    Olds ME
    Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diet-induced obesity and diet-resistant rats: differences in the rewarding and anorectic effects of D-amphetamine.
    Valenza M; Steardo L; Cottone P; Sabino V
    Psychopharmacology (Berl); 2015 Sep; 232(17):3215-26. PubMed ID: 26047964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine.
    Bjijou Y; Stinus L; Le Moal M; Cador M
    J Pharmacol Exp Ther; 1996 May; 277(2):1177-87. PubMed ID: 8627530
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repeated neurotensin administration in the ventral tegmental area: effects on baseline and D-amphetamine-induced locomotor activity.
    Elliott PJ; Nemeroff CB
    Neurosci Lett; 1986 Jul; 68(2):239-44. PubMed ID: 3748452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amphetamine-haloperidol discrimination: effects of chronic drug treatment.
    Haenlein M; Caul WF; Barrett RJ
    Pharmacol Biochem Behav; 1985 Dec; 23(6):949-52. PubMed ID: 4080781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spatial and temporal profile of haloperidol-induced immediate-early gene expression and phosphoCREB binding in the dorsal and ventral striatum of amphetamine-sensitized rats.
    Hsieh HC; Li HY; Lin MY; Chiou YF; Lin SY; Wong CH; Chen JC
    Synapse; 2002 Sep; 45(4):230-44. PubMed ID: 12125044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
    Skarsfeldt T
    Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased brain reward produced by ethanol withdrawal.
    Schulteis G; Markou A; Cole M; Koob GF
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5880-4. PubMed ID: 7597046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.